Terumo Corporation - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
TRUMY Over the counter 2830 www.terumo.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Terumo Corporation

Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth - Apr 1st, 2026 7:00 am
Did Terumo’s (TSE:4543) New Tata Elxsi Partnership and Bond Shelf Just Reframe Its Investment Narrative? - Mar 30th, 2026 5:06 am
Tata Elxsi Announces the Launch of a Global Offshore Development Center (ODC) for Terumo Corporation - Mar 19th, 2026 3:39 am
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update - Mar 12th, 2026 6:17 am
[Latest] Global Intravenous Infusion Pump Market Size/Share Worth USD 14.02 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Mar 9th, 2026 4:30 pm
Terumo Blood and Cell Technologies introduces APAC C> Ecosystem Blueprint - Mar 4th, 2026 7:10 pm
Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships - Feb 19th, 2026 2:35 am
Terumo Record Q3 Highlights OrganOx Integration And Margin Story For Investors - Feb 17th, 2026 8:21 am
Terumo Corp (TRUMF) Q3 2026 Earnings Call Highlights: Record Revenue and Strategic Acquisitions ... - Feb 16th, 2026 6:03 pm
Terumo Launches SurTract™ Safety Syringe in the United States, Powered by Roncadelle Operations' SafeR® Passive Safety Technology - Jan 6th, 2026 6:29 am
Santersus AG Completes Series A Financing and Announces Strategic Collaboration with Terumo Corporation - Dec 1st, 2025 7:00 am
Okami raises $45M to commercialize vascular embolization devices - Nov 24th, 2025 8:16 am
Terumo (TSE:4543): Evaluating Value After Prolonged Share Price Decline - Nov 15th, 2025 2:10 pm
US Shutdown End, FX, Earnings Nudge Asian Markets Higher - Nov 13th, 2025 3:51 am
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates - Nov 10th, 2025 2:10 pm
Cardiovascular Repair and Reconstruction Devices Report 2025-2034: Market Dominated by Medtronic, Terumo, W. L. Gore & Associates, and Getinge as Patent, Funding, and Innovation Activities Grow - Nov 6th, 2025 8:24 am
Orchestra BioMed to Host Business Update Call on November 12, 2025 - Nov 3rd, 2025 6:00 am
Terumo completes $1.5bn acquisition of OrganOx - Oct 31st, 2025 4:01 am
OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation - Oct 30th, 2025 6:00 am
Geisinger and Terumo Neuro Advance Stroke Education and Neurovascular Innovation in Recognition of World Stroke Day 2025 - Oct 29th, 2025 1:00 pm